Table 5 Professional satisfaction measures pre- and post-intervention
From: Integrating dermatologists in primary care: impact on delays, patient and professional experiences
Intervention group | Control group | |||||
|---|---|---|---|---|---|---|
Pre | Post | p value | Pre | Post | p value | |
n (%) | n (%) | n (%) | n (%) | |||
n | 24 | 28 | 14 | 9 | ||
Education of the professional | 0.575 | 0.436 | ||||
Specialist | 4 (16.7%) | 3 (10.7%) | 0 (0.0%) | 0 (0.0%) | ||
Licentiate | 5 (20.8%) | 9 (32.1%) | 2 (14.3%) | 3 (33.3%) | ||
Medical student | 0 (0.0%) | 0 (0.0%) | 1 (7.1%) | 0 (0.0%) | ||
Nurse | 15 (62.5%) | 15 (53.6%) | 11 (78.6%) | 6 (66.7%) | ||
Other | 0 (0.0%) | 1 (3.6%) | 0 (0.0%) | 0 (0.0%) | ||
Working experience | 0.064 | 0.495 | ||||
< 3 months | 0 (0.0%) | 2 (7.1%) | 1 (7.1%) | 0 (0.0%) | ||
3–9 months | 1 (4.2%) | 6 (21.4%) | 1 (7.1%) | 0 (0.0%) | ||
> 9 months | 23 (95.8%) | 20 (71.4%) | 12 (85.7%) | 9 (100.0%) | ||
Satisfaction with care pathway | < 0.001 | 0.018 | ||||
Very satisfied | 2 (8.7%) | 20 (71.4%) | 1 (7.7%) | 5 (55.6%) | ||
Satisfied | 8 (34.8%) | 4 (14.3%) | 7 (53.9%) | 4 (44.4%) | ||
Neutral | 7 (30.4%) | 4 (14.3%) | 5 (38.5%) | 0 (0.0%) | ||
Unsatisfied | 5 (21.7%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | ||
Very unsatisfied | 1 (4.4%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | ||
Net Promoter Score NPS | < 0.001 | 0.102 | ||||
Detractors | 9 (40.9%) | 0 (0.0%) | 1 (10.0%) | 0 (0.0%) | ||
Passives | 11 (50.0%) | 5 (17.7%) | 6 (60.0%) | 2 (22.2%) | ||
Promoters | 2 (9.1%) | 23 (82.1%) | 3 (30.0%) | 7 (77.8%) | ||
NPS Total | - 31.8% | 82.1% | 20.0% | 77.8% | ||
Post questionnaire only | ||||||
Managing a patient with a skin disorder is: | ||||||
Easier | 21 (80.8%) | 7 (77.8%) | ||||
More complicated | 1 (3.8%) | 1 (11.1%) | ||||
No different | 4 (15.4%) | 1 (11.1%) | ||||
The new care pathway reduces workload | ||||||
Yes | 15 (60.0%) | 6 (66.7%) | ||||
No | 10 (40.0%) | 3 (33.3%) | ||||
My ability to treat skin conditions has improved | ||||||
A lot | 3 (11.5%) | 1 (11.1%) | ||||
Somewhat | 11 (42.3%) | 4 (44.4%) | ||||
Not at all | 12 (46.2%) | 4 (44.4%) | ||||
The new care pathway is more beneficial to the patient than the previous model | ||||||
Yes | 26 (100.0%) | 9 (100.0%) | ||||
No | 0 (0.0%) | 0 (0.0%) | ||||
I would like to continue with the new care pathway | ||||||
Yes | 25 (96.1%) | 9 (100.0%) | ||||
No | 1 (3.9%) | 0 (0.0%) | ||||